Development of an antigen-based approach to noninvasively image CAR T cells in real time and as a predictive tool
Science Advances · 20.09.2024 · 10 (38)
DOI: 10.1126/sciadv.adn3816 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 20.09.2024. Verfasst von Julia Fröse und 14 weiteren Autor:innen. Beteiligte Einrichtung: David H. Koch Institute for Integrative Cancer Research, Cambridge, MA 02142, USA. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Immunotherapy, Adoptive, T-Lymphocytes. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
CAR T cell therapy has revolutionized the treatment of a spectrum of blood-related malignancies. However, treatment responses vary among cancer types and patients. Accurate monitoring of CAR T cell dynamics is crucial for understanding and evaluating treatment efficacy. Positron emission tomography (PET) offers a comprehensive view of CAR T cell homing, especially in critical organs such as lymphoid structures and bone marrow. This information will help assess treatment response and predict relapse risk. Current PET imaging methods for CAR T require genetic modifications, limiting clinical use. To overcome this, we developed an antigen-based imaging approach enabling whole-body CAR T cell imaging. The probe detects CAR T cells in vivo without affecting their function. In an immunocompetent B cell leukemia model, CAR-PET signal in the spleen predicted early mortality risk. The antigen-based CAR-PET approach allows assessment of CAR T therapy responses without altering established clinical protocols. It seamlessly integrates with FDA-approved and future CAR T cell generations, facilitating broader clinical application.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- David H. Koch Institute for Integrative Cancer Research, Cambridge, MA 02142, USA.
- Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
- Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
- Harvard Medical School, Boston, MA 02215, USA.
- Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA.
- Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA.
ORCID-Profile: Julia Fröse, Jennifer Rowley, Ali Salehi Farid, Paul Leclerc, Howard Mak, Harris Allen, Luis Millan-Barea, Hannah Glockner, Michael Hemann, Mohammad Rashidian
Förderung
- NCI NIH HHS
Zitieren
APA
Fröse, J., Rowley, J., Farid, A. S., Rakhshandehroo, T., Leclerc, P., Mak, H., Allen, H., Moravej, H., Munaretto, L., Millan-Barea, L., Codet, E., Glockner, H., Jacobson, C., Hemann, M., & Rashidian, M. (2024). Development of an antigen-based approach to noninvasively image CAR T cells in real time and as a predictive tool. Science Advances, 10(38). https://doi.org/10.1126/sciadv.adn3816
Vancouver
Fröse J, Rowley J, Farid AS, Rakhshandehroo T, Leclerc P, Mak H, et al. Development of an antigen-based approach to noninvasively image CAR T cells in real time and as a predictive tool. Science Advances. 2024;10(38). doi:10.1126/sciadv.adn3816
BibTeX
@article{Frse2024,
author = {Fröse, Julia and Rowley, Jennifer and Farid, Ali Salehi and Rakhshandehroo, Taha and Leclerc, Paul and Mak, Howard and Allen, Harris and Moravej, Heydar and Munaretto, Leila and Millan-Barea, Luis and Codet, Elisabeth and Glockner, Hannah and Jacobson, Caron and Hemann, Michael and Rashidian, Mohammad},
title = {Development of an antigen-based approach to noninvasively image CAR T cells in real time and as a predictive tool},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {38},
doi = {10.1126/sciadv.adn3816}
}
EUVIMED